Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

HISTORICAL FACTS: 3 | History Defined

Biotech Ingredients Are Beauty’s Next Big Thing—Here’s How They’re Changing Skincare as We Know It

Planet-approved skincare

Marie Claire

Celularity Inc. Surges Over 8% Pre-Market Amid Florida Stem Cell Policy, New Partnership Boost

Celularity Inc. (NASDAQ:CELU), a biotechnology company based in the United States, saw an 8.04% rise in the stock value in the pre-market hours on Tuesday.

Benzinga

Gene-edited pigs may soon enter the Canadian market, but questions about their impact remain

The Canadian government is currently considering approving the entry of gene-edited pigs into the food system.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Zhengye Biotechnology Stock Is Trading Lower On Monday: What's Going On?

Zhengye Biotechnology Holding (NASDAQ:ZYBT) shares are trading lower after the company announced it received a Nasdaq noncompliance notice.

Benzinga

What Are BioTechnology Industry Experts Saying About AI? How Will It Impact Future Tech?

What are BioTechnology industry experts saying about AI? How will it impact future tech?

International Business Times UK

Prince of Wales and Cate Blanchett don lab coats to see eco brand at work

William and the actress visited labs in Norwich where Colorifix, a biotechnology firm, creates its textile dyes.

Evening Standard

Marine fungi could help feed the world and fight disease

Fungi are nature’s recyclers and chemists, turning waste into useful products and creating an array of enzymes and compounds. By harnessing this potential through fungal biotechnology (using fungi to develop products and technologies for various applications), we can create sustainable materials, food and processes that help solve global challenges like…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Beyond de-extinction and dire wolves, gene editing can help today’s endangered species

Have you been hearing about the dire wolf lately? Maybe you saw a massive white wolf on the cover of Time magazine or a photo of “Game of Thrones” author George R.R. Martin holding a puppy named after a character from his books.

The Conversation

How Is Moderna’s Stock Performance Compared to Other Biotechnology Stocks?

Moderna has significantly underperformed other biotechnology stocks over the past year, and analysts remain cautious on the stock’s prospects.

Barchart

2 Biopharmaceutical Stocks Focused on Cancer That Wall Street Predicts Will More Than Double

Analysts are uber bullish on Actuate Therapeutics and PDS Biotechnology stocks for the next 12 months. Here’s why.

Barchart

Designer DNA and Ethical Eating: The Brave New World of Biotech Arrives in the UK

Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised treatments and sustainable, ethical meat alternatives.

International Business Times UK

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

The Independent UK

Cancer research in the US is world class because of its broad base of funding − with the government pulling out, its future is uncertain

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology startups, federal agencies and private foundations. As a cancer biologist who has worked in each of these sectors over the past three…

The Conversation

Ghana’s first genetically modified crop: why we created a new cowpea variety, how we tested it and what we found

Cowpea (Vigna unguiculata) is an indigenous and staple crop in sub-Saharan Africa, but it has an enemy: an insect called the legume pod borer (Maruca vitrata). This pest can cause yield losses of more than 80%. The pod borer, originally from south-east Asia, attacks the flowers, pods and seeds.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

UP: BSc student ends life in hostel room soon after talking to fiance

A final-year BSc student of biotechnology at Veer Bahadur Singh Purvanchal University allegedly committed suicide by hanging herself in her hostel room soon after talking to her fiance over phone

The Conversation

How to engineer microbes to enable us to live on Mars

A field known as synthetic biology has become one of the most highly anticipated in science. Its outputs range from golden rice, which is genetically engineered to provide vitamin A, to advances stemming from the Human Genome Project, which successfully mapped the entire human genome. Prominent voices in biotechnology have…

MarketBeat

Pharma Frenzy: Volatility Ignites Biotech Sector

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

Newslaundry

Public money, private patents? Unravelling India’s opacity over its Covid vaccines

Public money, private patents: Unravelling India’s opacity over its Covid vaccines

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Woolly mice are a first step to resurrecting mammoths, but there’s a very long way to go

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly mammoth from extinction. In a preprint paper published on March 4, scientists at Colossal report making a significant step towards this objective. They genetically modified the DNA of mice to give them mammoth-like…

The Times of India

The emerging role of AI in complementing human expertise in the early detection of breast cancer

Breast cancer has been a significant global health concern, being most commonly detected cancer in women and contributes to the highest number of cancer-related fatalities among women. Surprisingly, it stands as fourth leading cause of all cancer-related deaths globally. India at the cusp of it, faces a significant burden of…

USA Today Sports Media Group

Purchasing HeLa Cells: What You Need to Know

HeLa cells, the world's first immortal human cell line, have played a crucial role in advancing scientific research and biotechnology. Derived from the cervical cancer cells of Henrietta Lacks in 1951, HeLa cells have been indispensable in numerous ...

Barchart

This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025.

With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock.

StockNews.com

3 Biotech Innovators Advancing Genetic Therapies

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global regulations. Considering the advancements, fundamentally solid biotech stocks Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN) are emerging as top choices for investors seeking transformative opportunities. Read further….

Dynamite News

India emerges as a global leader across key sectors in 2024

The year 2024 marked a pivotal year for India, showcasing its dominance in pharmaceuticals, biotechnology, defense, nuclear energy, space, infrastructure, and emerging technologies like quantum computing, AI, and blockchain. Read further on Dynamite News:

StockNews.com

3 Healthcare ETFs for Defensive Investing

The healthcare sector is poised for strong growth, driven by aging populations, technological advancements, and increased service demand. Thus, to gain exposure to the healthcare sector, one could capitalize on iShares Biotechnology (IBB), SPDR S&P Health Care Equipment (XHE), and iShares U.S. Medical Devices (IHI). Read on….

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.